Article Versions Notes

Nusman CM, Snoek L, van Leeuwen LM, Dierikx TH, van der Weijden BM, Achten NB, Bijlsma MW, Visser DH, van Houten MA, Bekker V, et al. Group B Streptococcus Early-Onset Disease: New Preventive and Diagnostic Tools to Decrease the Burden of Antibiotic Use. Antibiotics. 2023; 12(3):489. https://doi.org/10.3390/antibiotics12030489

Nusman, Charlotte M., Linde Snoek, Lisanne M. van Leeuwen, Thomas H. Dierikx, Bo M. van der Weijden, Niek B. Achten, Merijn W. Bijlsma, Douwe H. Visser, Marlies A. van Houten, Vincent Bekker, and et al. 2023. "Group B Streptococcus Early-Onset Disease: New Preventive and Diagnostic Tools to Decrease the Burden of Antibiotic Use" Antibiotics 12, no. 3: 489. https://doi.org/10.3390/antibiotics12030489

Nusman, C. M., Snoek, L., van Leeuwen, L. M., Dierikx, T. H., van der Weijden, B. M., Achten, N. B., Bijlsma, M. W., Visser, D. H., van Houten, M. A., Bekker, V., de Meij, T. G. J., van Rossem, E., Felderhof, M., & Plötz, F. B. (2023). Group B Streptococcus Early-Onset Disease: New Preventive and Diagnostic Tools to Decrease the Burden of Antibiotic Use. Antibiotics, 12(3), 489. https://doi.org/10.3390/antibiotics12030489